The global vaccine market is growing rapidly, having seen double-digit growth for the last 10 years. Without a doubt, Asia is now seen as a highly lucrative and important market for global vaccine manufacturers to break into. According to estimations, the vaccine market is expected to grow from $2.3 billion back in 2006 to $16.6 billion by 2016 with biggest opportunities lying in developing and emerging markets such as China, India and other Asia Pacific countries.
However, Asia remains as a very challenging market for many international stakeholders. Cultural barriers, complex regulatory systems, government influences and lack of talents and technological breakthroughs are some of the common challenges faced by new market entrants.
We interviewed 383 industry professionals, who shared views about their opinions and interests about the vaccine industry in Asia.
Of the 383 industry professionals surveyed, the following topics showed to be of great importance:
1. Alliances and Partnership in the Asian Vaccine Market
2. Regulatory Compliance in Asia
3. Platform Technology Applied in Emerging Infectious Diseases